Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Teresa Amaral

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|April 3, 2021
Endoglin in the Spotlight to Treat CancerTeresa González Muñoz, Ana Teresa Amaral, Pilar Puerto-Camacho, et al.
Cells|April 1, 2020
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular LandscapeCarmen Salguero-Aranda, Ana Teresa Amaral, Joaquín Olmedo-Pelayo, et al.
Cancers|December 23, 2022
Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue SarcomaCarmen Salguero-Aranda, Joaquín Olmedo-Pelayo, Enrique de Álava, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 22, 2026
Next generation CAR-T cells to tackle down solid tumorsTeresa Abreu, Ana Godinho-Santos, Ana Teresa Amaral, et al.
Advances in Anatomic Pathology|December 10, 2013
Innovative therapies in Ewing SarcomaAna Teresa Amaral, José Luis Ordóñez, Ana Pastora Otero-Motta, et al.
Plos One|May 26, 2011
IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosisAna Sofia Martins, José Luis Ordóñez, Ana Teresa Amaral, et al.
Advances in Anatomic Pathology|April 27, 2010
The clinical relevance of molecular genetics in soft tissue sarcomasJosé Luis Ordóñez, Daniel Osuna, Daniel J García-Domínguez, et al.
Plos One|February 6, 2014
Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implicationsAna Teresa Amaral, Maria Cristina Manara, Dagmar Berghuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agentsAna Teresa Amaral, Cecilia Garofalo, Roberta Frapolli, et al.
Cell Death & Disease|February 16, 2023
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic MimicryDaniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|April 3, 2021
Endoglin in the Spotlight to Treat CancerTeresa González Muñoz, Ana Teresa Amaral, Pilar Puerto-Camacho, et al.
Cells|April 1, 2020
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular LandscapeCarmen Salguero-Aranda, Ana Teresa Amaral, Joaquín Olmedo-Pelayo, et al.
Cancers|December 23, 2022
Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue SarcomaCarmen Salguero-Aranda, Joaquín Olmedo-Pelayo, Enrique de Álava, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 22, 2026
Next generation CAR-T cells to tackle down solid tumorsTeresa Abreu, Ana Godinho-Santos, Ana Teresa Amaral, et al.
Advances in Anatomic Pathology|December 10, 2013
Innovative therapies in Ewing SarcomaAna Teresa Amaral, José Luis Ordóñez, Ana Pastora Otero-Motta, et al.
Plos One|May 26, 2011
IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosisAna Sofia Martins, José Luis Ordóñez, Ana Teresa Amaral, et al.
Advances in Anatomic Pathology|April 27, 2010
The clinical relevance of molecular genetics in soft tissue sarcomasJosé Luis Ordóñez, Daniel Osuna, Daniel J García-Domínguez, et al.
Plos One|February 6, 2014
Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implicationsAna Teresa Amaral, Maria Cristina Manara, Dagmar Berghuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agentsAna Teresa Amaral, Cecilia Garofalo, Roberta Frapolli, et al.
Cell Death & Disease|February 16, 2023
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic MimicryDaniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, et al.
Pageof 2